Content area
Full text
Scottsdale-based Medicis Pharmaceutical Corp. has added 50 positions associated with the launch of its product Restylane, an injection for face wrinkles that was just approved by the U.S. Food and Drug Administration.
About 33 of those positions are in the sales field, while the remainder are at the company's Scottsdale headquarters, said Jonah Shacknai, chairman and chief executive of Medicis.
Although he declined to specify salaries, he did say the new jobs...